Terms: = Bone cancer AND DDIT3, CHOP, 1649, ENSG00000175197, _C/EBP zeta_, MGC4154, GADD153, CHOP10, P35638 AND Treatment
289 results:
1. Role of plasma EBV-DNA load and EBER status on newly diagnosed peripheral T-cell lymphoma.
Chen J; Zhou J; Cheng F; Chen D; Guan F; Zhang E; He J; Cai Z; Zhao Y
J Cancer Res Clin Oncol; 2024 Apr; 150(4):181. PubMed ID: 38587664
[TBL] [Abstract] [Full Text] [Related]
2. Expression of the chemokine receptor CCR1 decreases sensitivity to bortezomib in multiple myeloma cell lines.
Zeissig MN; Hewett DR; Mrozik KM; Panagopoulos V; Wallington-Gates CT; Spencer A; Dold SM; Engelhardt M; Vandyke K; Zannettino ACW
Leuk Res; 2024 Apr; 139():107469. PubMed ID: 38479337
[TBL] [Abstract] [Full Text] [Related]
3. Primary thyroid lymphoma: a case series.
Sakhri S; Zemni I; Ayadi MA; Kamoun S; Chargui R; Ben Dhiab T
J Med Case Rep; 2024 Feb; 18(1):108. PubMed ID: 38395921
[TBL] [Abstract] [Full Text] [Related]
4. [Successful cord blood transplantation for refractory gamma-delta hepatosplenic T-cell lymphoma developed during treatment of Crohn's disease].
Saito A; Nara M; Fujishima T; Kuroki W; Yamashita T; Kobayashi T; Ikeda S; Kitadate A; Kameoka Y; Takahashi N
Rinsho Ketsueki; 2024; 65(1):41-46. PubMed ID: 38311388
[TBL] [Abstract] [Full Text] [Related]
5. Long-term outcomes with HLX01 (HanliKang
Qin Y; Song Y; Wang D; Bai O; Feng J; Sun X; Qiu L; Yang J; Yang Y; Wang Z; Hu J; Wang H; Su H; Jin Z; Qian W; Jin C; Zhang M; Yu D; Liu L; Chen G; Li Y; Sun T; Jin J; Bao H; Du X; Zhou H; Fu G; Shi Y
BMC Cancer; 2024 Jan; 24(1):124. PubMed ID: 38267866
[TBL] [Abstract] [Full Text] [Related]
6. Genetic Characterization of Primary Mediastinal B-Cell Lymphoma: Pathogenesis and Patient Outcomes.
Noerenberg D; Briest F; Hennch C; Yoshida K; Hablesreiter R; Takeuchi Y; Ueno H; Staiger AM; Ziepert M; Asmar F; Locher BN; Toth E; Weber T; Amini RM; Klapper W; Bouzani M; Poeschel V; Rosenwald A; Held G; Campo E; Ishaque N; Stamatopoulos K; Kanellis G; Anagnostopoulos I; Bullinger L; Goldschmidt N; Zinzani PL; Bödör C; Rosenquist R; Vassilakopoulos TP; Ott G; Ogawa S; Damm F
J Clin Oncol; 2024 Feb; 42(4):452-466. PubMed ID: 38055913
[TBL] [Abstract] [Full Text] [Related]
7. The impact of chop versus bendamustine on bone mineral density in patients with indolent lymphoma enrolled in the GALLIUM study.
Pedersen MA; Gormsen LC; Jakobsen LH; Eyre TA; Severinsen MT; Baech J; Dann EJ; Knapp A; Sahin D; Vestergaard P; El-Galaly TC; Jensen P
Br J Haematol; 2024 Apr; 204(4):1271-1278. PubMed ID: 37957542
[TBL] [Abstract] [Full Text] [Related]
8. Clinicopathologic and mutational profiles of primary breast diffuse large B cell lymphoma in a male patient: case report and literature review.
Huang F; Ruan Y; He X; Lian H; Yang J
World J Surg Oncol; 2023 Oct; 21(1):342. PubMed ID: 37884941
[TBL] [Abstract] [Full Text] [Related]
9. Metformin sensitizes AML cells to venetoclax through endoplasmic reticulum stress-chop pathway.
Hua L; Yang N; Li Y; Huang K; Jiang X; Liu F; Yu Z; Chen J; Lai J; Du J; Zeng H
Br J Haematol; 2023 Sep; 202(5):971-984. PubMed ID: 37409755
[TBL] [Abstract] [Full Text] [Related]
10. Hepatosplenic T-cell lymphoma presented with massive splenomegaly and pancytopenia - a case report.
Sukrisman L; Rajabto W; Harahap AS; Fanggidae ESDE; Ham MF; Priantono D
Klin Onkol; 2023; 36(3):246-250. PubMed ID: 37353354
[TBL] [Abstract] [Full Text] [Related]
11. Rituximab versus obinutuzumab-based first-line chemoimmunotherapy for follicular lymphoma-a real-world multicenter retrospective cohort study.
Berger T; Shochat T; Aumann S; Nachmias B; Goldschmidt N; Horesh N; Harel R; Aviv A; Shmerts E; Abadi U; Shimony S; Raanani P; Gafter-Gvili A; Gurion R
Ann Hematol; 2023 Aug; 102(8):2127-2136. PubMed ID: 37335322
[TBL] [Abstract] [Full Text] [Related]
12. Circulating biosignatures in multiple myeloma and their role in multidrug resistance.
Krishnan SR; Bebawy M
Mol Cancer; 2023 Apr; 22(1):79. PubMed ID: 37120508
[TBL] [Abstract] [Full Text] [Related]
13. TP53 mutations identify high-risk events for peripheral T-cell lymphoma treated with chop-based chemotherapy.
Johnson WT; Ganesan N; Epstein-Peterson ZD; Moskowitz AJ; Stuver RN; Maccaro CR; Galasso N; Chang T; Khan N; Aypar U; Lewis NE; Zelenetz AD; Palomba ML; Matasar MJ; Noy A; Hamilton AM; Hamlin P; Caron PC; Straus DJ; Intlekofer AM; Lee Batlevi C; Kumar A; Owens CN; Sauter CS; Falchi L; Lue JK; Vardhana SA; Salles G; Dogan A; Schultz ND; Arcila ME; Horwitz SM
Blood Adv; 2023 Sep; 7(17):5172-5186. PubMed ID: 37078708
[TBL] [Abstract] [Full Text] [Related]
14. Propofol Regulates ER Stress to Inhibit Tumour Growth and Sensitize Osteosarcoma to Doxorubicin.
Wei H; Du X; Zhao H; Sun P; Yang J
Int J Clin Pract; 2023; 2023():3093945. PubMed ID: 36756222
[TBL] [Abstract] [Full Text] [Related]
15. High-intensity chemotherapy improved the prognosis of patients with high-grade B-cell lymphoma.
Chen Y; Cai Q; Chang Y; Zhang M; Li Z
Front Immunol; 2022; 13():1047115. PubMed ID: 36618391
[TBL] [Abstract] [Full Text] [Related]
16. Early efficacy and safety of obinutuzumab with chemotherapy in previously untreated patients with follicular lymphoma: A real-world retrospective report of the Polish Lymphoma Research Group.
Paszkiewicz-Kozik E; Hus I; Palka M; Dębowska M; Końska A; Kotarska M; Tyczyńska A; Joks M; Twardosz M; Giza A; Wąsik-Szczepanek E; Kalicińska E; Wiśniewska A; Morawska M; Lewicka B; Szymański M; Targoński Ł; Romejko-Jarosińska J; Drozd-Sokołowska J; Subocz E; Swoboda R; Długosz-Danecka M; Lech-Maranda E; Walewski J
Adv Clin Exp Med; 2023 Jan; 32(1):131-136. PubMed ID: 36603138
[TBL] [Abstract] [Full Text] [Related]
17. Incidence and risk factors for central nervous system relapse in patients with primary mediastinal large B-cell lymphoma in the rituximab era.
Vassilakopoulos TP; Panitsas F; Mellios Z; Apostolidis J; Michael M; Gurion R; Ferhanoglu B; Hatzimichael E; Karakatsanis S; Dimou M; Kalpadakis C; Katodritou E; Leonidopoulou T; Kotsianidis I; Giatra H; Kanellias N; Sayyed A; Tadmor T; Akay OM; Angelopoulou MK; Horowitz N; Bakiri M; Pangalis GA; Panayiotidis P; Papageorgiou SG
Hematol Oncol; 2023 Feb; 41(1):97-107. PubMed ID: 36314897
[TBL] [Abstract] [Full Text] [Related]
18. Clinical characteristics and prognosis of patients with co-existing follicular lymphoma and diffuse large B-cell lymphoma components in rituximab era.
Chen Y; Luo L; Chen L; Zheng X; Yang X; Zheng Z; Zheng J; Liu T; Yang T; Hu J
J Cancer Res Clin Oncol; 2023 Jun; 149(6):2311-2318. PubMed ID: 36219261
[TBL] [Abstract] [Full Text] [Related]
19. Intravascular Large B-Cell Lymphoma: A Review with a Focus on the Prognostic Value of Skin Involvement.
Breakell T; Waibel H; Schliep S; Ferstl B; Erdmann M; Berking C; Heppt MV
Curr Oncol; 2022 Apr; 29(5):2909-2919. PubMed ID: 35621627
[TBL] [Abstract] [Full Text] [Related]
20. Zoledronic acid-induced oxidative damage and endoplasmic reticulum stress-mediated apoptosis in human embryonic kidney (HEK-293) cells.
Kara M; Boran T; Öztaş E; Jannuzzi AT; Özden S; Özhan G
J Biochem Mol Toxicol; 2022 Aug; 36(8):e23083. PubMed ID: 35587103
[TBL] [Abstract] [Full Text] [Related]
[Next]
